Stay informed with the latest litigation news. Explore now

IP Verse

Amgen Inc. vs. Regeneron Pharmaceuticals Inc. - APL_51683/2024

Explore detailed information on the case number APL_51683/2024 involving Amgen Inc. and Regeneron Pharmaceuticals Inc. which was filed on 13 Sep, 2024.

Case Details

    Case Number:

    APL_51683/2024

    Patent Number:

    EP3666797

    Filing Date:

    13 Sep, 2024

    Proceeding Type:

    Appeal

    Action/Application:

    Appeal Rop220.1

    Plaintiffs:

    • Amgen Inc. Represented By Johannes Heselberger

    Defendants:

    • Regeneron Pharmaceuticals Inc. Represented By Niels Hoelder

    Judges:

    • Cornelis Schüller
    • Ingeborg Simonsson
    • Patricia Rombach
    • Rainer Friedrich
    • Rian Kalden

    Court Division:

    Appeal Instance - Seat - Luxembourg

Case Decision

Decision pending - set alert to receive updates

More cases involving EP3666797B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Sep 4, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_51679/2024Sep 13, 2024AmgenSanofi-Aventis Deutschland Gmbh, Sanofi-Aventis Groupe, Sanofi Winthrop Industrie S.A.
CC_586764/2023Nov 10, 2023Regeneron Pharmaceuticals Inc.Amgen Inc.
ACT_459916/2023Jun 26, 2023Amgen Inc.Regeneron Pharmaceuticals Inc., Sanofi-Aventis Groupe S.A., Sanofi Winthrop Industrie S.A., Sanofi-Aventis Deutschland Gmbh

More cases involving Amgen Inc.

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Sep 4, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen AB, Amgen Biofarmaceutica LDA, Amgen, Amgen, Amgen Zdravila DOO, Amgen, Amgen, Amgen Technology Ireland Unlimited -
App_35086/2025Aug 20, 2025Amgen Technology Ireland Unlimited, Amgen, Amgen, Amgen AB, Amgen, Amgen, Amgen Biofarmaceutica LDA, Amgen Zdravila DOO -
App_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Technology Ireland Unlimited, Amgen Biofarmaceutica LDA, Amgen, Amgen Zdravila DOO, Amgen, Amgen -

More cases involving Regeneron Pharmaceuticals Inc.

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Sep 4, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_43914/2024Jul 29, 2024Amgen Inc.Sanofi Winthrop Industrie S.A., Sanofi-Aventis Deutschland Gmbh, Regeneron Pharmaceuticals Inc., Sanofi-Aventis Groupe S.A.
CC_24999/2024May 3, 2024Amgen Europe B.V., Amgen Inc., Amgen B.V., Amgen S.R.L., Amgen Nv, Amgen Gmbh, Amgen S.A.S.Regeneron Pharmaceuticals Inc.
ACT_459916/2023Jun 26, 2023Amgen Inc.Regeneron Pharmaceuticals Inc., Sanofi-Aventis Groupe S.A., Sanofi Winthrop Industrie S.A., Sanofi-Aventis Deutschland Gmbh